A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
Condition:   Fabry's Disease Interventions:   Drug: AGALSIDASE BETA (GZ419828);   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Dexamethasone;   Drug: Montelukast Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials